Stratos Wealth Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $712K | Sell |
10,182
-369
| -3% | -$25.8K | 0.01% | 812 |
|
2025
Q1 | $776K | Sell |
10,551
-2,925
| -22% | -$215K | 0.01% | 743 |
|
2024
Q4 | $883K | Sell |
13,476
-835
| -6% | -$54.7K | 0.01% | 738 |
|
2024
Q3 | $1.12M | Buy |
14,311
+170
| +1% | +$13.2K | 0.02% | 641 |
|
2024
Q2 | $1.1M | Sell |
14,141
-454
| -3% | -$35.4K | 0.02% | 612 |
|
2024
Q1 | $989K | Buy |
14,595
+1,002
| +7% | +$67.9K | 0.02% | 652 |
|
2023
Q4 | $916K | Sell |
13,593
-261
| -2% | -$17.6K | 0.02% | 662 |
|
2023
Q3 | $938K | Buy |
13,854
+864
| +7% | +$58.5K | 0.02% | 600 |
|
2023
Q2 | $930K | Buy |
12,990
+3,394
| +35% | +$243K | 0.02% | 558 |
|
2023
Q1 | $666K | Sell |
9,596
-3,838
| -29% | -$266K | 0.02% | 594 |
|
2022
Q4 | $911K | Sell |
13,434
-477
| -3% | -$32.3K | 0.02% | 534 |
|
2022
Q3 | $763K | Sell |
13,911
-1,071
| -7% | -$58.7K | 0.02% | 558 |
|
2022
Q2 | $990K | Sell |
14,982
-2,932
| -16% | -$194K | 0.03% | 519 |
|
2022
Q1 | $1.19M | Sell |
17,914
-196
| -1% | -$13K | 0.03% | 509 |
|
2021
Q4 | $1.06M | Sell |
18,110
-6,014
| -25% | -$350K | 0.02% | 546 |
|
2021
Q3 | $1.45M | Sell |
24,124
-625
| -3% | -$37.5K | 0.04% | 418 |
|
2021
Q2 | $1.48M | Sell |
24,749
-3,505
| -12% | -$210K | 0.04% | 427 |
|
2021
Q1 | $1.41M | Buy |
28,254
+1,028
| +4% | +$51.1K | 0.04% | 408 |
|
2020
Q4 | $1.36M | Buy |
27,226
+16,886
| +163% | +$844K | 0.04% | 367 |
|
2020
Q3 | $567K | Sell |
10,340
-238
| -2% | -$13.1K | 0.02% | 579 |
|
2020
Q2 | $560K | Buy |
+10,578
| New | +$560K | 0.02% | 559 |
|
2018
Q2 | – | Sell |
-4,047
| Closed | -$142K | – | 1096 |
|
2018
Q1 | $142K | Buy |
4,047
+318
| +9% | +$11.2K | 0.01% | 1029 |
|
2017
Q4 | $129K | Sell |
3,729
-3,638
| -49% | -$126K | 0.01% | 1050 |
|
2017
Q3 | $250K | Buy |
+7,367
| New | +$250K | 0.01% | 763 |
|
2014
Q3 | – | Sell |
-23,962
| Closed | -$891K | – | 333 |
|
2014
Q2 | $891K | Buy |
+23,962
| New | +$891K | 0.3% | 98 |
|